Sharesies worth more than NZX with $500m valuation

Sharesies worth more than NZX with $500m valuation
The three Sharesies CEOs – Brooke Roberts, Sonya Williams, and Leighton Roberts – each own a 5.4% stake, worth $27m apiece. (Photo: supplied)
Dan Brunskill
Sharesies latest capital raise, led by global venture firm Amplo, has more than tripled the investment platform’s value which is now worth half a billion dollars.The company was founded in 2017 with the goal of making investing in NZ equities easier but is now worth more than the stock exchange it first provided access to.If it were listed on the NZX, Sharesies would now have a market capitalisation just below fleet management firm Eroad – at $517m – and just above stock market operator NZX, worth $485m.The privately-owned inv...

More Markets

Average home insurance tops $2,000
Infrastructure Risky Business

Average home insurance tops $2,000

Insurance premiums in New Zealand have increased dramatically in recent years.

How RFK Jnr's Medicare reform could aid this NZ firm
Markets

How RFK Jnr's Medicare reform could aid this NZ firm

'Wild west' conditions hampered its US push. They could be changing.

Pacific Edge 'star of the day' on NZX
Markets Market Close

Pacific Edge 'star of the day' on NZX

The S&P/NZX 50 Index closed up 0.17% or 22.50 points.

Tom Raynel 10 Sep 2025
US CMS recommends 30% increase for Pacific Edge's Cxbladder Triage Plus price
Markets

US CMS recommends 30% increase for Pacific Edge's Cxbladder Triage Plus price

Cancer diagnostics company Pacific Edge has announced that the United States' Centers for Medicare & Medicaid Services (CMS) recommended a final “gapfill” price for its Cxbladder Triage Plus.CMS is proposing a price of US$1,328.32 (NZ$2,241.71), which is about 30% higher than...

Staff reporters 10 Sep 2025